Publication:
Rituximab SC and IV Plus CHOP Show Similar Efficacy and Safety in the Randomized Mabease Study in First-Line DLBCL

Simple item page
dc.contributor.authorLugtenburg, P.
dc.contributor.authorAvivi, I.
dc.contributor.authorBerenschot, H.
dc.contributor.authorIlhan, O.
dc.contributor.authorMarolleau, J. P.
dc.contributor.authorNagler, A.
dc.contributor.authorPfreundschuh, M.
dc.date.accessioned2020-06-21T13:19:13Z
dc.date.available2020-06-21T13:19:13Z
dc.date.issued2017
dc.departmentOMÜen_US
dc.department-temp[Lugtenburg, P.] Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands -- [Avivi, I.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel -- [Berenschot, H.] Albert Schweitzer Hosp, Dept Hematol, Dordrecht, Netherlands -- [Ilhan, O.] Ankara Univ, Dept Hematol, Sch Med, Ankara, Turkey -- [Marolleau, J. P.] Univ Hosp Amiens, Hematol Unit, Amiens, France -- [Nagler, A.] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel -- [Rueda, A.] Unidad Oncol Med, Area Oncol, Marbella, Spainen_US
dc.description22nd Congress of the European-Hematology-Association -- JUN 22-25, 2017 -- Madrid, SPAINen_US
dc.description.abstract…en_US
dc.description.sponsorshipEuropean Hematol Assocen_US
dc.identifier.endpage5en_US
dc.identifier.issn0390-6078
dc.identifier.startpage4en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/12397
dc.identifier.volume102en_US
dc.identifier.wosWOS:000404127001008
dc.language.isoenen_US
dc.publisherFerrata Storti Foundationen_US
dc.relation.journalHaematologicaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titleRituximab SC and IV Plus CHOP Show Similar Efficacy and Safety in the Randomized Mabease Study in First-Line DLBCLen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu